International Reference Pricing and Negotiation: Yes or No?
Drug prices are a pressing policy issue. On November 20, 2020, President Donald Trump announced two new...
The Regulatory Transparency Project is a nonprofit, nonpartisan effort dedicated to fostering discussion and a better understanding of regulatory policies.
Drug prices are a pressing policy issue. On November 20, 2020, President Donald Trump announced two new...
Regulatory Transparency Project's Fourth Branch Podcast
In this episode, an expert panel looks at what the new year may bring regarding the...
Regulatory Transparency Project's Fourth Branch Podcast
There are nearly 500,000 commercial drones registered in the United States, far exceeding recent FAA...
Regulatory Transparency Project's Fourth Branch Podcast
How is insurance regulated in the United States? How are emerging technologies disrupting the industry? And...
Regulatory Transparency Project's Fourth Branch Video
Technology has made it possible for people to virtually access their healthcare providers. During COVID-19,...